Ablevia

biotech

selective antibody removal

<

research & development

about us

partners & contact

 We remove disease-causing and neutralizing antibodies 

​

 [(c) stock.adobe.com]

Ablevia biotech GmbH

Maria Jacobi Gasse 1, MQM 3.2

1030 Vienna

AUSTRIA

contact us

<

member of

funding

& partners

supported by BMWFW / aws & FFG

Initial private investments in combination with non-dilutive funding by federal institutions, supports technology setup and facilitates Ablevia's independence in seed phase. Ablevia has received funding from the Austrian Research Promotion Agency (FFG Early Stage program) and was awarded a Seedfinancing program by the Austrian promotional bank aws.

Austrian Research Promotion Agency

impressum

Location on Google Maps - here

selective antibody removal therapeutics